Blair William & CO Arcturus Therapeutics Holdings Inc. Transaction History
Blair William & CO
- $32 Billion
- Q2 2024
A detailed history of Blair William & CO transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Blair William & CO holds 17,830 shares of ARCT stock, worth $450,207. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,830
Previous 18,135
1.68%
Holding current value
$450,207
Previous $612,000
29.08%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ARCT
# of Institutions
186Shares Held
25.9MCall Options Held
320KPut Options Held
153K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$119 Million0.28% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$66.9 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.96MShares$49.6 Million0.44% of portfolio
-
Nikko Asset Management Americas, Inc.1.56MShares$39.5 Million0.44% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.56MShares$39.5 Million0.03% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $671M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...